Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes

Journal of Medical Virology

Volumn 52, Issue 1, 1997, Pages 68-76

  Khattab, Barbara Anna Maria ^a   Lindenmaier, Werner ^b   Frank, Ronald ^b   Link, Hartmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Gesell F Biotechnologische F ^*  (Germany)

Author keywords

HLA anchor motifs; human cytomegalovirus; matrix protein pp65; peptide antigens; T cell response

Indexed keywords

HLA ANTIGEN CLASS 2; MATRIX PROTEIN;

ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; NONHUMAN; T LYMPHOCYTE; VIRUS CELL INTERACTION;

ALLELES; AMINO ACID SEQUENCE; CELL LINE; CYTOMEGALOVIRUS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 0030943502     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199705)52:1<68::AID-JMV11>3.0.CO;2-X     Document Type: Article

References (41)

1. Alp NJ, Allport TD, van Zanten J, Rodgers B, Sissons JGP, Borysiewicz LK (1991): Fine specificity of cellular immune responses to human cytomegalovirus immediate-early 1 protein. Journal of Virology 65:4812-4820.
2. Beninga J, Kropff B, Mach M (1995): Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. Journal of General Virology 76:153-160.
3. Brodsky FM, Guagliardi LE (1991): The cell biology of antigen processing and presentation. Annual Review of Immunology 9:707-744.
4. Charpentier B, Michelson S, Martin B (1986): Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system. Journal of Immunology 137:330-336.
5. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchinson III CA, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG (1990): Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169. In McDougall JK (ed): "Current Topics in Microbiology and Immunology 154." Berlin: Springer Verlag, pp 125-169.
6. Forman SJ, Zaia JA, Clark BR, Wright CL, Mills BJ, Pottathil R, Racklin BC, Gallagher MT, Welte K, Blume KG (1985): A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. Journal of Immunology 134:3391-3395.
7. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ (1993): Alkali hydrolysis of recombinant proteins allows for the rapid identification of Class I MHC-restricted CTL epitopes. Journal of Immunology 151:3971-3980.
8. Gehrz RC (1991): Human cytomegalovirus: Biology and clinical perspectives. Advances in Pediatrics 38:203-232.
9. Gilbert MJ, Riddell SR, Li C-R, Greenberg PD (1993): Selective interference with Class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. Journal of Virology 67:3461-3469.
10. Gönczöl E, Ianacone J, Ho W, Starr S, Meignier B, Plotkin S (1990): The isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune responses in human volunteers. Vaccine 8:130-136.
11. Gorensek MJ, Stewart RW, Keys TF, McHenry MC, Goormastic M (1988): A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. Journal of Infectious Diseases 157:515-522.
12. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Tokacs B, Sinigaglia F (1993): Promiscuous and allele-specific anchors in HLA-DR-binding peptidcs. Cell 74:197-203.
13. Hammer J, Nagy ZA, Sinigaglia F (1994): Rules governing peptide-class II MHC molecule interactions. Behring Institut Mitteilungen 94:124-132.
14. Harris PE, Maffei A, Liu Z, Colovai I, Reed EF, Inghirami G, Suciu-Foca N (1993): Naturally processed cytokine-derived peptide bound to HLA-class II molecules. Journal of Immunology 151: 5975-5983.
15. He H, Rinaldo CR, Morel PA (1995): T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: Implications for vaccine development. Journal of General Virology 76:1603-1610.
16. Malcherek G, Gnau V, Jung G, Rammensee H-G, Melms A (1995): Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. Journal of Experimental Medicine 181:527-536.
17. Jacobson MA, Mills J (1988): Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Annals of Internal Medicine 108:585-594.
18. + T lymphocytes. Journal of Virology 64:5457-5465.
19. Khattab B, Kassubek B, Lindenmaier W, Link H (1994): Polyclonal T cell response to human cytomegalovirus pp65. 20th European Bone Marrow Transplantation Conference, Harrogate, United Kingdom, 13-17 March 1994. Abstract 119, p 124.
20. Landini MP, Guan MX, Jahn G, Lindenmaier W, Mach M, Ripalti A, Necker A, Lazzarotto T, Plachter B (1990): Large-scale screening of human sera with cytomegalovirus recombinant antigens. Journal of Clinical Microbiology 28:1375-1379.
21. Li C-R, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR (1994): Recovery of HLA-restricted cytomegalovirus (HCMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with HCMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979.
22. Lindenmaier W, Necker A, Krause S, Bonewald R, Collins J (1990): Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system. Archives of Virology 113:1-16.
23. Link H, Battmer K, Kleine HD (1992): Detection of cytomegalovirus-infected cells by flow cytometry and fluorescence in suspension hybridisation (FLASH) using DNA probes labeled with biotin by polymerase chain reaction. Journal of Medical Virology 37:143-148.
24. Link H, Battmer K, Stumme C (1993): Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization. British Journal of Haematology 85: 573-577.
25. Liu Y-N, Klaus A, Kari B, Stinski MF, Eckhardt J, Gehrz RC (1991): The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans. Journal of Virology 65:1644-1648.
26. Liu Y-N, Curtsinger J, Donahue PR, Klaus A, Opitz G, Cooper J, Karr RW, Bach FH, Gehrz RC (1993): Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93. Journal of General Virology 74:2207-2214.
27. Loftus DJ, Kubo RT, Sakaguchi K, Celis E, Sette A, Appella E (1995): Analysis of MHC-specific peptide motifs. In Atassi MZ, Bixler Jr. GS (eds): "Immunobiology of Proteins and Peptides VIII. Manipulation or Modulation of the Immune Response". New York: Plenum Press, pp 201-210.
28. + virus-specific cytotoxic T lymphocytes. Journal of Medical Virology 43:103-110.
29. O'Sullivan D, Sidney J, Appella E, Walker L, Phillips L, Colon S, Miles C, Chesnut R, Sette A (1990): Characterization of the specificity of peptide binding to four DR haplotypes. Journal of Immunology 145:1799-1808.
30. Pass RF, Duliege A-M, Boppana SB, Britt WJ, Granoff DM, Sekulovich R, Burke RL (1995): A phase I trial of BIOCINE CMV gB vaccine in seronegative adults. Fifth International Cytomegalovirus Conference, Stockholm, Sweden, 21-24 May 1995. Abstract 031, p 76.
31. Polic B, Jonjic S, Pavic I, Crnkovic I, Dujmovic M, Zorica I, Hengel H, Kucic N, Lucin P, Koszinowski UH (1995): Control of cytomegalovirus infection in MHC class I deficient mice. Scandinavian Journal of Infectious Diseases Suppl. 99:52-53.
32. Rammensee HG, Friede T, Stefanovic S (1995): MHC ligands and peptide motifs: First listing. Immunogenetics 41:178-228.
33. Reddehase MJ, Mutter W, Koszinowski UH (1987): In vivo application of recombinant interleukin2 in the immunotherapy of established cytomegalovirus infection. Journal of Experimental Medicine 165: 650-656.
34. Reusser P, Riddell SR, Meyers JD, Greenberg PD (1991): Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
35. + cytotoxic T lymphocyte responses to human cytomegalovirus in immunodeficient humans by the adoptive transfer of T cell clones. In Michelson S, Plotkin SA (eds): "Multidisciplinary Approach to Understanding Cytomegalovirus Disease." Amsterdam: Elsevier Science Publishers B.V., pp 155-164.
36. Rodgers B, Borysiewicz L, Mundin J, Graham S, Sissons P (1987): Immunoaffinity purification of a 72k early antigen of human cytomegalovirus: Analysis of humoral and cell-mediated immunity to the purified polypeptide. Journal of General Virology 68:2371-2378.
37. Stinski MF (1978): Sequence of proteins synthesis in cells infected with human cytomegalovirus: Early and late viral-induced polypeptides. Journal of Virology 26:686-701.
38. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR (1995): Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine 333:1038-1044.
39. Wills MR, Carmichael AJ, Jin X, Sissons JGP (1995): Limiting dilution analysis of cytotoxic T-cells directed towards human cytomegalovirus: comparison of CTL specific to IE1 and a structural protein (pp65). Fifth International Cytomegalovirus Conference, Stockholm, Sweden, 21-24 May 1995. Abstract 010, p 65.
40. Wronska D, Jones J, Browne H, Wilkinson G, Minson AC, Sissons JGP, Borysiewicz LK (1993): The human cytomegalovirus MHC class I homologue induces an allospecific cytotoxic T cell response. In Michelson S, Plotkin SA (eds). "Multidisciplinary Approach to Understanding Cytomegalovirus Disease." Amsterdam: Elsevier Science Publishers B.V., pp 321-326.
41. Zaia JA (1994): Cytomegalovirus infection. In Forman SJ, Blume KG, Thomas ED (eds): "Bone Marrow Transplantation." Cambridge: Blackwell Scientific Publications, pp 376-403.